Pcs Drug Screening Inc is categorized under Outpatient Drug Clinics in Saint Louis, MO and active since 2008.
Pcs Drug Screening Inc was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Outpatient Drug Clinics business, which does work in the B2C market, and is classified as a Outpatient Drug Clinics, under code number 6215110 by the NAICS.
If you are seeking more information, feel free to contact Pam Mueller, Director at the company’s single location by writing to 8300 Valcour Avenue, Saint Louis, Missouri MO 63123 or by phoning (314) 752-1100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pcs Drug Screening Inc |
| Contact Person: | Pam Mueller, Director |
| Address: | 8300 Valcour Avenue, Saint Louis, Missouri 63123 |
| Phone Number: | (314) 752-1100 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Outpatient Drug Clinics |
| SIC Code: | 8093 |
| NAICS Code: | 6215110 |
| Share This Business: |
Pcs Drug Screening Inc was started in 2008 to provide professional Outpatient Drug Clinics under the SIC code 8093 and NAICS code 6215110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Pam Mueller, Director for inquiries that concern Pcs Drug Screening Inc by calling the company number (314) 752-1100, as your correspondence is most welcome. Additionally, the physical location of the single location of Pcs Drug Screening Inc can be found at the coordinates 38.56275,-90.33415 as well as the street address 8300 Valcour Avenue in Saint Louis, Missouri 63123.
For its online presence, you may visit Pcs Drug Screening Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.